Holen Sie sich die Stockscreener-App
8.665
1.94%
0.165
Schlusskurs vom Vortag:
$8.50
Offen:
$8.54
24-Stunden-Volumen:
21,801
Relative Volume:
0.02
Marktkapitalisierung:
$582.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-103.21M
KGV:
-1.8837
EPS:
-4.6001
Netto-Cashflow:
$-26.70M
1W Leistung:
-2.09%
1M Leistung:
+5.29%
6M Leistung:
+126.24%
1J Leistung:
+6.98%
1-Tages-Spanne:
$8.43
$8.695
1-Wochen-Bereich:
$8.08
$9.04
52-Wochen-Spanne:
$2.65
$11.14
Engene Holdings Inc Stock (ENGN) Company Profile
Firmenname
Engene Holdings Inc
Sektor
Branche
Telefon
(514) 332-4888
Adresse
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Vergleichen Sie ENGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
8.695 | 569.37M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.00 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.42 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.45 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.41 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-14 | Herabstufung | UBS | Buy → Neutral |
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-27 | Eingeleitet | Raymond James | Outperform |
| 2024-11-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-03-28 | Eingeleitet | UBS | Buy |
| 2024-03-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten
Aug Highlights: Can enGene Holdings Inc Equity Warrant stock sustain free cash flow growth2025 Pullback Review & Consistent Income Trade Recommendations - moha.gov.vn
Can enGene Holdings Inc. stock double in next 5 yearsNew Guidance & Safe Entry Momentum Stock Tips - ulpravda.ru
How geopolitical tensions affect enGene Holdings Inc. Equity Warrant stockQuarterly Market Summary & High Yield Stock Recommendations - ulpravda.ru
Short Covering: Is enGene Holdings Inc. Equity Warrant stock a dividend growth opportunity - ulpravda.ru
Is enGene Holdings Inc. Equity Warrant stock a dividend growth opportunityTrade Performance Summary & Growth-Oriented Investment Plans - ulpravda.ru
Is enGene Holdings Inc. stock safe for conservative investorsJuly 2025 Gainers & Reliable Price Action Trade Plans - ulpravda.ru
Is enGene Holdings Inc. stock a contrarian buy2025 Retail Activity & Consistent Income Trade Recommendations - ulpravda.ru
enGene Holdings Inc Stock Analysis and ForecastValue Traps to Avoid & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Citizens reiterates Market Outperform rating on Engene stock with $21 target - Investing.com Canada
Citizens reiterates Market Outperform rating on Engene stock with $21 target By Investing.com - Investing.com South Africa
enGene (NASDAQ:ENGN) Shares Gap Up – Should You Buy? - Defense World
enGene (NASDAQ:ENGN) Shares Gap UpStill a Buy? - MarketBeat
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN) - Seeking Alpha
ETFs Investing in enGene Holdings Inc. Stocks - TradingView — Track All Markets
While Institutions Invested in EnGene Holdings Inc. (NASDAQ:ENGN) Benefited From Last Week's 21% Gain, Private Equity Firms Stood to Gain the Most - 富途牛牛
Analysts Offer Insights on Healthcare Companies: enGene Holdings (ENGN) and Agios Pharma (AGIO) - The Globe and Mail
HC Wainwright Forecasts enGene's Q1 Earnings (NASDAQ:ENGN) - MarketBeat
enGene (NASDAQ:ENGN) Sees Large Volume IncreaseHere's Why - MarketBeat
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages By Investing.com - Investing.com South Africa
enGene (NASDAQ:ENGN) Trading Up 4.6%What's Next? - MarketBeat
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages - Investing.com Nigeria
enGene Reports Full Year 2025 Financial Results and Provides Business Update - BioSpace
enGene completes enrollment in bladder cancer treatment trial - Investing.com India
enGene completes enrollment in bladder cancer treatment trial By Investing.com - Investing.com Nigeria
EnGene Fiscal 2025 Loss Widens - marketscreener.com
enGene (NASDAQ:ENGN) Announces Earnings Results - MarketBeat
enGene Holdings Inc. SEC 10-K Report - TradingView — Track All Markets
EnGene Holdings Inc. Reports Earnings Results for the Full Year Ended October 31, 2025 - marketscreener.com
enGene announces proposed public offering - MSN
Will enGene Holdings Inc. stock rally after Fed decisionsTrade Entry Report & Fast Exit and Entry Trade Guides - Улправда
Is enGene Holdings Inc. Equity Warrant stock a top pick in earnings season2025 Volume Leaders & Verified Swing Trading Watchlists - Улправда
Weekly Recap: Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Catalysts & Expert Curated Trade Setups - Улправда
Will enGene Holdings Inc. stock benefit from AI adoption2025 Market WrapUp & Long Hold Capital Preservation Tips - bolumsonucanavari.com
Valuation Update: Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Closing Moves & AI Powered Buy and Sell Recommendations - Улправда
Is enGene Holdings Inc. Equity Warrant stock a good choice for value investorsWeekly Profit Recap & Fast Moving Trade Plans - Улправда
How enGene Holdings Inc. stock performs in stagflationJuly 2025 Decliners & AI Driven Price Forecasts - Улправда
How sustainable is enGene Holdings Inc. Equity Warrant stock dividend payout2025 Support & Resistance & Fast Entry High Yield Stock Tips - Улправда
Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Patterns & AI Powered Trade Plan Recommendations - Улправда
How enGene Holdings Inc. Equity Warrant stock performs in weak economyOil Prices & Weekly Setup with ROI Potential - DonanımHaber
How enGene Holdings Inc. stock performs in high volatility marketsPortfolio Update Report & Daily Volume Surge Signals - DonanımHaber
Insider Trends: Is enGene Holdings Inc. Equity Warrant stock a good choice for value investors2025 Technical Patterns & Safe Capital Growth Stock Tips - Улправда
Quarterly Risk: Is enGene Holdings Inc. Equity Warrant stock a top pick in earnings season2025 Earnings Impact & Weekly Return Optimization Alerts - Улправда
enGene Shares Gain 5% After Bladder Cancer Therapy Shows Stronger Response Rates - MSN
enGene Holdings Inc. (NASDAQ:ENGN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
enGene Holdings Inc. (NASDAQ:ENGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
enGene (NASDAQ:ENGN) Shares Gap DownShould You Sell? - MarketBeat
enGene Holdings Inc trading resumes - MSN
enGene Holdings Amends CEO Severance Package - MSN
enGene (NASDAQ:ENGN) Stock Price Up 8.2%Time to Buy? - MarketBeat
Finanzdaten der Engene Holdings Inc-Aktie (ENGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):